Facilitated Poster Sessions: Discussion of original research, award-winning projects, and pharmacy practice projects
Séance animée de présentations par affiches : Discussions sur des projets de recherche originale, des projets primes, et des projets dans le domaine de la pratique pharmaceutique
Acute Kidney Injury with Tobramycin-Impregnated Bone Cement Spacers in Prosthetic Joint Infections: A Controlled Study
Comparison of the Accuracy of 4 Sets of Criteria at Predicting Presence of Pseudomonas aeruginosa in Patients Admitted for Pneumonia
Trends of Antibiotic Use in the Inpatient Acute Care Setting: Is There Evidence of Seasonality?
Efficacy and Safety of Atazanavir plus Raltegravir Dual Therapy in Treatment-Experienced HIV-1 Infected Patients
Outcomes in Documented Pseudomonas aeruginosa Bacteremia Treated with Intermittent Infusion Intravenous Ceftazidime, Meropenem, and Piperacillin/Tazobactam: A Retrospective Study
Impact of Infection with Extended-Spectrum ß-Lactamase (ESBL)-Producing Escherichia coli or Klebisella Species on Outcome and Hospitalization Costs
Tracking Dispensary Turnaround Time
Perceptions and Practices Associated with Reporting Adverse Drug Reactions among Medical and Pharmacy Residents in Quebec
Adherence to the Institute for Safe Medication Practices Canada’s “Do Not Use” List of Dangerous Abbreviations in Paper and Electronic Medication Orders
Opportunities to Enhance Institutional Experiential Education: Placing Students in Pairs Projects
Optimization of Workflow and Medication Safety in Unit Dose Dispensing
Antimicrobial Medications Incidents and Accidents and Consumption in 2012–2013
How Do Patient, Non-patient and Hospital Pharmacist Stakeholder Perspectives on Clinical Pharmacy Key Performance Indicators for Hospital Pharmacists Compare?
Standardization of Pharmacist Attendance at Rounds
Standardization of Pharmacists Involvement in Best Possible Medication History and Medication Reconciliation
Quality of Nurse-Acquired Best Possible Medication History in an Ambulatory Hemodialysis Centre
Assessing Completeness of Best Possible Medication History by Profession
Pharmacist Workload on General Medicine and Surgery Units
Evaluation of Interventions to Improve Management of Behavioural and Psychological Symptoms of Dementia in a Residential Care Facility
Single versus Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation: A Systemic Review
Evaluation of Enoxaparin Pharmacokinetics and Pharmacodynamics to Develop Dose Banding Based on Total Body Weight and Renal Function
Adherence to Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
Follow-up Point Prevalence Survey of Antimicrobial Use in the Cardiac and Paediatric Critical Care Unit
Telepharmacy Support of an Antimicrobial Stewardship Program in a Small Rural Acute Care Hospital
Evaluation of Inhaled Corticosteroid Prescribing for Chronic Obstructive Pulmonary Disease in Family Medicine Teaching Units
Stability of an Epidural Analgesic Admixture Containing Ropivacaine and Epinephrine in Cassette Reservoirs
Extended Stability of Sodium Phosphate Solutions in Polyvinylchloride Bags
Stability of 100 mg/mL Ertapenem in Syringes and the Manufacturer’s Glass Vial at 4C and 23C
Utilization of Dexmedetomidine in Patients Admitted to a Tertiary Care Medical Surgical Intensive Care Unit
Review of the Safety of Disease-Modifying Anti-rheumatic Drug Therapy in Patients with Chronic Kidney Disease
Recherche en pratique pharmaceutique : des recettes et astuces en ligne
Publications comportant des retombées négatives de l’activité pharmaceutique
Comparaison du niveau d’accord à des énoncés sur l’éthique pharmaceutique entre étudiants en pharmacie et pharmaciens hospitaliers canadiens
Littérature sur le rôle et les retombées du pharmacien : perceptions d’etudiants canadiens
Démarche pour la mise à niveau de soins pharmaceutiques : l’exemple de l’immunisation
The Evaluation of Paclitaxel Hypersensitivity Reactions Following the Discontinuation of Prophylactic Pre-Medications
Impact of Experiential Learning on the Professional and Personal Development of Undergraduate Pharmacy Students
Effectiveness of Extracurricular Journal Clubs on Pharmacy Students’ Learning of Evidence-Based Medicine and Critical Appraisal
An Environmental Scan of Transition Courses for Pharmacy Students Prior to Advanced Pharmacy Practice Experience Rotations
Adherence to Abiraterone among the First Eighty-Six Recipients Following Its Release in Saskatchewan, Canada
Development and Implementation of a Peer-Assisted Learning Model to Teach Pharmacy Students in a Clinical Trials Rotation
Opportunities to Enhance Institutional Experiential Education: Mutually Beneficial Activities Analysis
Doctor of Pharmacy Students Acquire Skills in Curriculum Design and Project Management through Participation in an Education Project with Coaching Support
Prevalence of Co-trimoxazole Induced Hyperkalemia in Chronic and Acute Users in a Tertiary Teaching Hospital
Planning and Evaluation of a Computerized Prescriber Order Entry Implementation
Patient–Perceived Usefulness and Usability of a Smartphone/Online Application in Type 2 Diabetes Self-Management
Pompes intelligentes : évaluation pratique des limites de détection
Retrospective Review of Emerging Drug Use in a Mother–Child Center in Quebec
Unlicensed and Off-Label Drug Use in a Mother–Child Tertiary Care Hospital
Is Pediatric Drug Information the Same for All Children Around the World?
Démarche pour la mise à niveau d’un secteur de soins pharmaceutiques : le cas de la pédiatrie
Conformité des ordonnances à la règle d’emission des médicaments : étude pilote au sein d’un CHU mère-enfant
Audit of the Labelling of Hazardous Drugs in the Canadian Market
Tolerability of Darunavir/Ritonavir, Tenofovir/Emtricitabine for Human Immunodeficiency Virus Postexposure Prophylaxis
Prophylaxis of Post-traumatic Infectious Endophthalmitis: Probability of Fluoroquinolone Success Using Monte Carlo Simulations
Natural Health Product Use in Patients with Rheumatological Conditions
Multidisciplinary Review Process Demonstrates the Need for Early Pharmacist Notification with Treatment Intervention Benefits in Clostridium difficile Infection (CDI)
Pharmacist’s Perception of the Implementation of Computerized Prescriber Order Entry (CPOE) on Their Practice
Anticoagulation and Antiplatelet Patterns in Patients with Atrial Fibrillation Post-percutaneous Coronary Intervention
A Pharmacy Practice Residency Program at a Paediatric Quaternary Hospital: Program Review and Evaluation
Patient Satisfaction with Chronic HIV Care Provided through an Innovative Pharmacist and Nurse-Managed Clinic or a Multidisciplinary Clinic
Use of Therapeutic Drug Monitoring to Improve Paediatric Clinical Pharmacy Service at a Tertiary Hospital
Guideline for the Prevention of Breakthrough and Treatment of Refractory Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients
Impact of Pharmacist Interventions on Outpatient Parenteral Antimicrobial Therapy Information Transfer at Hospital Discharge
Survey of Healthcare Professionals on the Role of Pharmacists in an Outpatient HIV Clinic Setting
Predictors of Bacteremia in the Elderly
Determination of Gentamicin Pharmacokinetics in Neonates to Develop Practical Initial Extended-Interval Dosing Recommendations
Impact of Length of Stay on the Distribution of Gram Negative Organisms and the Likelihood of Isolating a Resistant Organism in a Canadian Burn Centre
Customization and Implementation of a Compounding Software Solution for Safe and Efficient Sterile and Non-sterile Compounding
Correlation Between Length of Smoking Cessation Therapy and Rate of Abstinence in Pragmatic Conditions
CSHP 2015 is a quality program that sets out a vision of pharmacy practice excellence in the year 2015. Through this project, CSHP challenges hospital pharmacists to reach measurable targets for 36 objectives grouped under 6 goals, all aimed toward the effective, scientific, and safe use of medications and meaningful contributions to public health. CSHP 2015 applies to inpatients and outpatients, community and hospital pharmacists, and all practice settings. Posters identified with a “CSHP 2015” logo are those judged by the CSHP 2015 Steering Committee to be particularly relevant to one or more of the 36 objectives.
Le projet SCPH 2015 est un programme axé sur la qualité qui propose une vision de l’excellence en pratique pharmaceutique en l’an 2015. Au moyen de ce projet, la SCPH met les pharmaciens d’établissements au défi d’atteindre les cibles mesurables de 36 objectifs répartis entre 6 buts, visant tous l’utilisation efficace, scientifique et sûre des médicaments ainsi que des contributions significatives à la santé publique. Le projet SCPH 2015 s’applique aux patients hospitalisés et externes, aux pharmaciens d’hôpitaux et communautaires, et à tous les milieux de pratique. Les affiches marquées du logo « SCPH 2015 » sont celles que le Comité directeur du projet SCPH 2015 a jugé particulièrement appropriées à l’un ou l’autre des 36 objectifs.
The texts of poster abstracts are published exactly as submitted by the authors and have not undergone any copyediting by the Canadian Journal of Hospital Pharmacy. / Le Journal canadien de la pharmacie hospitalière n’a pas soumis le texte des résumés des affiches à une révision linguistique et les publie ici tels que remis par les auteurs.
E Aeng1, K Shalansky2, T Lau2, N Zalunardo2, W Bowie2, G Li2, C Duncan2
1Surrey Memorial Hospital, Surrey, BC
2Vancouver General Hospital, Vancouver, BCABSTRACT
Background:
Antibiotic-impregnated bone cement spacer (ACS) with tobramycin +/− vancomycin is commonly used in a two-stage replacement of an infected prosthetic joint.
Objectives:
We investigated the incidence and risk factors for acute kidney injury (AKI) within 7 days post-operatively after implantation of tobramycin-impregnated bone cement.
Methods:
This was a prospective, observational, controlled study of 119 patients from Aug 2011 to Feb 2013. The tobramycin group included 50 consecutive patients who received ACS with tobramycin for the first stage revision of an infected hip or knee arthoplasty. The control group consisted of 69 consecutive patients who had a routine hip arthroplasty revision without ACS. AKI was defined as an increase of 50% or greater in serum creatinine from baseline within the immediate 7-day post-operative day (POD) period.
Results:
The incidence of AKI was higher in the tobramycin group compared to the control group (20% vs. 4.3%, p=0.01). A multivariate analysis adjusting for potential confounders also confirmed the higher incidence of AKI in patients receiving tobramycin ACS (OR 7.2; 95% CI 1.5–33.5). Mean onset of AKI was on POD 3 in both groups and patients with AKI had longer duration of hospital stay (18.6 ± 13.7 days vs 8.8 ± 7.0 days, p < 0.0001). Other risk factors for AKI were baseline co-morbidity (OR 6.2; 95% CI 1.3–29.1), and administration of post-operative intravenous vancomycin (OR 5.3; 95% CI 1.6–17.7) or angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (OR 4.0; 95% CI 1.2–13.04). Use of pre-manufactured bone cement containing gentamicin was also a risk factor in the tobramycin group (OR 4.5, 95% CI 1.1–19.3).
Conclusions:
The incidence of AKI in infected hip or knee arthroplasties with tobramycin ACS was greater than in routine total hip arthoplasties. Measures to minimize AKI risk in the peri-operative period may reduce the incidence.